Seroincidence of 2009 H1N1 infection in HIV-infected and HIV-uninfected women prior to vaccine availability

Keri N. Althoff; Maryna Eichelberger; Stephen J. Gange; Gerald B. Sharp; Jin Gao; Marshall J. Glesby; Mary Young; Ruth M. Greenblatt; Audrey L. French; Maria C. Villacres; Howard Minkoff

doi:10.1097/QAD.0b013e3283471cf2

Seroincidence of 2009 H1N1 infection in HIV-infected and HIV-uninfected women prior to vaccine availability

Keri N. Althoff, Maryna Eichelberger, Stephen J. Gange, Gerald B. Sharp, Jin Gao, Marshall J. Glesby, Mary Young, Ruth M. Greenblatt, Audrey L. French, Maria C. Villacres, Howard Minkoff

Bloomberg School of Public Health

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

The 2009 H1N1 pandemic was a unique opportunity to investigate differences in influenza infection using serology by HIV status. Using serial serum specimens collected from 1 April to 30 September 2009 and the prior 2 years from Women,s Interagency HIV study participants, there was no difference in serologic evidence of 2009 H1N1 infection among HIV-infected women with a CD4 cell count at least 350 cells/μl compared with HIV-uninfected women. Owing to evidence showing a greater risk of influenza-related complications, HIV-infected individuals should continue to be a priority group for vaccination.

Original language	English (US)
Pages (from-to)	1229-1232
Number of pages	4
Journal	AIDS
Volume	25
Issue number	9
DOIs	https://doi.org/10.1097/QAD.0b013e3283471cf2
State	Published - Jun 1 2011

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Infectious Diseases

Access to Document

10.1097/QAD.0b013e3283471cf2

Cite this

@article{1a8f4004423d4c5a9043e67417624434,

title = "Seroincidence of 2009 H1N1 infection in HIV-infected and HIV-uninfected women prior to vaccine availability",

abstract = "The 2009 H1N1 pandemic was a unique opportunity to investigate differences in influenza infection using serology by HIV status. Using serial serum specimens collected from 1 April to 30 September 2009 and the prior 2 years from Women,s Interagency HIV study participants, there was no difference in serologic evidence of 2009 H1N1 infection among HIV-infected women with a CD4 cell count at least 350 cells/μl compared with HIV-uninfected women. Owing to evidence showing a greater risk of influenza-related complications, HIV-infected individuals should continue to be a priority group for vaccination.",

author = "Althoff, {Keri N.} and Maryna Eichelberger and Gange, {Stephen J.} and Sharp, {Gerald B.} and Jin Gao and Glesby, {Marshall J.} and Mary Young and Greenblatt, {Ruth M.} and French, {Audrey L.} and Villacres, {Maria C.} and Howard Minkoff",

year = "2011",

month = jun,

day = "1",

doi = "10.1097/QAD.0b013e3283471cf2",

language = "English (US)",

volume = "25",

pages = "1229--1232",

journal = "AIDS",

issn = "0269-9370",

publisher = "Lippincott Williams and Wilkins",

number = "9",

}

TY - JOUR

T1 - Seroincidence of 2009 H1N1 infection in HIV-infected and HIV-uninfected women prior to vaccine availability

AU - Althoff, Keri N.

AU - Eichelberger, Maryna

AU - Gange, Stephen J.

AU - Sharp, Gerald B.

AU - Gao, Jin

AU - Glesby, Marshall J.

AU - Young, Mary

AU - Greenblatt, Ruth M.

AU - French, Audrey L.

AU - Villacres, Maria C.

AU - Minkoff, Howard

PY - 2011/6/1

Y1 - 2011/6/1

N2 - The 2009 H1N1 pandemic was a unique opportunity to investigate differences in influenza infection using serology by HIV status. Using serial serum specimens collected from 1 April to 30 September 2009 and the prior 2 years from Women,s Interagency HIV study participants, there was no difference in serologic evidence of 2009 H1N1 infection among HIV-infected women with a CD4 cell count at least 350 cells/μl compared with HIV-uninfected women. Owing to evidence showing a greater risk of influenza-related complications, HIV-infected individuals should continue to be a priority group for vaccination.

AB - The 2009 H1N1 pandemic was a unique opportunity to investigate differences in influenza infection using serology by HIV status. Using serial serum specimens collected from 1 April to 30 September 2009 and the prior 2 years from Women,s Interagency HIV study participants, there was no difference in serologic evidence of 2009 H1N1 infection among HIV-infected women with a CD4 cell count at least 350 cells/μl compared with HIV-uninfected women. Owing to evidence showing a greater risk of influenza-related complications, HIV-infected individuals should continue to be a priority group for vaccination.

UR - http://www.scopus.com/inward/record.url?scp=85027919556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027919556&partnerID=8YFLogxK

U2 - 10.1097/QAD.0b013e3283471cf2

DO - 10.1097/QAD.0b013e3283471cf2

M3 - Article

AN - SCOPUS:85027919556

VL - 25

SP - 1229

EP - 1232

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 9

ER -

Seroincidence of 2009 H1N1 infection in HIV-infected and HIV-uninfected women prior to vaccine availability

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this